We have recently developed a Corynebacterium glutamicum strain that generates NADPH via the glycolytic pathway by replacing endogenous NAD-dependent glyceraldehyde 3-phosphate dehydrogenase (GapA) with a nonphosphorylating NADP-dependent glyceraldehyde 3-phosphate dehydrogenase (GapN) from Streptococcus mutans. Strain RE2, a suppressor mutant spontaneously isolated for its improved growth on glucose from the engineered strain, was proven to be a high-potential host for L-lysine production (Takeno et al., 2010) . In this study, the suppressor mutation was identified to be a point mutation in rho encoding the transcription termination factor Rho. Strain RE2 still showed retarded growth despite the mutation rho696. Our strategy for reconciling improved growth with a high level of L-lysine production was to use GapA together with GapN only in the early growth phase, and subsequently shift this combination-type glycolysis to one that depends only on GapN in the rest of the growth phase. To achieve this, we expressed gapA under the 2 myo-inositol-inducible promoter of iolT1 encoding a myo-inositol transporter in strain RE2. The resulting strain RE2A iol was engineered into an L-lysine producer by introduction of a plasmid carrying the desensitized lysC, followed by examination for culture conditions with myo-inositol supplementation. We found that as a higher concentration of myo-inositol was added to the seed culture, the following fermentation period became shorter while maintaining a high level of L-lysine production. This finally reached a fermentation period comparable to that of the control GapA strain, and yielded a 1.5-fold higher production rate compared with strain RE2. The transcript level of gapA, as well as the GapA activity, in the early growth phase increased in proportion to the myo-inositol concentration and then fell to low levels in the subsequent growth phase, indicating that improved growth was a result of increased GapA activity, especially in the early growth phase. Moreover, blockade of the pentose phosphate pathway through a defect in glucose 6-phosphate dehydrogenase did not significantly affect L-lysine production in the engineered GapN strains, while a drastic decrease in L-lysine production was observed for the control GapA strain. Determination of the intracellular NADPH/NADP + ratios revealed that the ratios in the engineered strains were significantly higher than the ratio of the control GapA strain irrespective of the pentose phosphate pathway. These results demonstrate that our strain engineering strategy allows efficient L-lysine production independent of the oxidative pentose phosphate pathway.
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L-Lysine has been manufactured by the fermentation method using mutants of Corynebacterium glutamicum; currently, 2,200,000 tons of L-lysine per year is produced almost exclusively by this method (Eggeling and Bott, 2015) . The supply of reducing power, NADPH, is a critical factor for efficient L-lysine production, because 1 mol of L-lysine requires 4 mol of NADPH for its biosynthesis from glucose in C.
glutamicum (Moritz et al., 2002) . It has been reported in this organism that NADPH is generated mainly through the oxidative pentose phosphate pathway (PPP) (Marx et al., 1996) . Several reports have shown that redirection of carbon from glycolysis toward the PPP leads to a significant improvement in L-lysine production (Becker et al., 2011 (Becker et al., , 2007 (Becker et al., , 2005 ; Marx et al., 2003; Ohnishi et al., 2005) . Despite this positive effect, relying on the PPP is disadvantageous in terms of carbon yield, because the pathway inevitably involves the release of 1 mol of carbon dioxide accompanied by the oxidation of 1 mol of hexose (Contador et al., 2009) . This drawback suggests a limitation for using the PPP to produce L-lysine.
Progress in genome science has led to an in silico construction of an organism's entire metabolic map. Diverse metabolic pathways of approximately 3,500 bacterial species have already been constructed (Kanehisa et al., 2014; at http://www.kegg.jp/kegg-bin/get_htext?htext=br08601_map00010.keg&hier=5). We noticed using the database that some bacterial species natively lack the complete PPP.
Our interest was how such bacteria supply NADPH. Regarding this, Streptococcus mutans, which lacks the oxidative part of the PPP because of the absence of two NADP-dependent enzymes, glucose 6-phosphate dehydrogenase (G6PDH) and 6-phosphogluconate dehydrogenase, is known to have a nonphosphorylating NADP-dependent glyceraldehyde 3-phosphate dehydrogenase (GapN) as an alternative source of NADPH ( Fig. S1 ; Crow and Wittenberger, 1979) . GapN catalyzes the irreversible oxidation of glyceraldehyde 3-phosphate (GAP) to 3-phosphoglycerate. We conceived that construction of the S. mutans-type glycolytic pathway in C. glutamicum would remove the need for the PPP, leading to more efficient production of L-lysine and 4 presumably other NADPH-requiring compounds due to the avoidance of carbon loss through the oxidative PPP.
C. glutamicum ATCC 13032 originally has two glyceraldehyde 3-phosphate dehydrogenases, GapA and GapB. GapA, an NAD-dependent enzyme, is responsible for both glycolysis and gluconeogenesis, and GapB, which represents a dual cofactor signature with a preference for NADP and thus has NADPH-generating potency in the glycolytic direction, works only for gluconeogenesis (Ikeda and Nakagawa, 2003; Takeno et al., 2010) . Initially, we isolated the mutants that use GapB for glycolysis from the ΔgapA strain. However, the resulting isolates showed insufficient growth on glucose at a level that did not allow for efficient L-lysine production. This suggested that there would be difficulties in exploiting the endogenous enzyme for an NADPH-generating glycolytic pathway. Accordingly, we decided to use the heterologous S. mutans GapN enzyme to engineer C. glutamicum ( Fig. 1 ). For this purpose, we replaced the deleted gapA gene of the ΔgapAB double-deleted mutant with the intact gapN gene from S.
mutans to generate a gapN-expressing strain, strain GPN (Takeno et al., 2010) .
Unfortunately, the growth of strain GPN on glucose was significantly retarded despite reconstruction of a functional glycolytic pathway. However, a suppressor mutant with an increased ability to utilize sugars was spontaneously isolated from strain GPN.
Analysis of the suppressor mutant RE2 showed that no mutation was present in and upstream of the gapN gene, and that the NADP-dependent GapN activity level was unchanged from that of its parental strain GPN (Takeno et al., 2010) . Moreover, it was concluded that another mutated enzyme(s) that could functionally substitute for the GapN reaction is most unlikely to emerge in strain RE2 because no suppressor mutant was obtained from ΔgapAB strain. Thus, the glycolysis in strain RE2 was concluded to be fully dependent on the NADP-dependent GapN. This suppressor mutant was shown to be a more likely potential host for L-lysine production than the wild-type and ΔgapB strains. We also ruled out the possibility that increased L-lysine production is a result of the unknown suppressor mutation(s), by demonstrating using strain RE2A that 5 replacement of the chromosomal gapN gene in strain RE2 with the gapA gene reduced L-lysine production to the same level as that of the control ΔgapB strain (Takeno et al., 2010) . In the present study, the suppressor mutation was identified.
Despite the presence of the suppressor mutation, a limitation of strain RE2 for efficient production is its severely retarded growth relative to the wild-type and ΔgapB strains. Here, we show a strategy to shorten the fermentation period of strain RE2 while keeping its high-level L-lysine productivity using GapA only in the early growth phase.
In addition, the effect of blocking the PPP through a defect in G6PDH on growth and L-lysine productivity was investigated in the engineered strains.
Materials and methods

Bacterial strains, plasmids, and primers
All strains used in this study are derivative mutants of the wild-type C.
glutamicum strain ATCC 13032. The ΔgapB, GPN, and RE2 strains were previously described (Takeno et al., 2010) . In brief, each strain was constructed as follows. The ΔgapB strain was constructed by an in-frame deletion of the gapB gene in wild-type ATCC 13032. Strain GPN was constructed by replacing the deleted gapA gene in the ∆gapAB double-deleted mutant of wild-type ATCC 13032 with the intact gapN gene from S. mutans. Strain RE2, a suppressor mutant with an increased ability to utilize sugars, was spontaneously isolated from strain GPN. E. coli DH5α was used as a host for DNA manipulation. Plasmid pCAK311 (Takeno et al., 2010) , which contains the desensitized lysC gene [lysC (T311I)], was used to create L-lysine-producing strains.
Plasmid pESB30 (Mitsuhashi et al., 2004) , which is nonreplicative in C. glutamicum, is a vector for gene replacement in C. glutamicum. The primer sequences used in this study are presented in Table S1 in the Supplemental material. All primers were designed based on the genomic sequences of C. glutamicum (BA000036) and S. mutans 6 (AE014133), which are publicly available at http://www.genome.jp/kegg/genes.html.
Media and culture conditions
Minimal medium MM (Takeno et al., 2007) , complete medium BY (Takeno et al., 2007) , and LFG1 medium for L-lysine production (Takeno et al., 2010) were used to cultivate C. glutamicum strains. C. glutamicum cells that had been cultured for 1 day on a BY plate containing 20 mg/L of kanamycin were inoculated into 30 mL of BY medium containing glucose and/or myo-inositol at the indicated concentrations, 1%
CaCO 3 , and 50 mg/L of kanamycin (seed medium) in a 300-mL baffled Erlenmeyer flask, followed by rotary shaking at 200 rpm. After the glucose initially added into the seed medium was consumed, 3 mL of the seed culture was transferred into 30 mL of LFG1 medium containing 5% glucose, 3% CaCO 3 , and 200 mg/L of kanamycin in a 300-mL baffled Erlenmeyer flask, followed by rotary shaking at 200 rpm. All cultivations were done at 30ºC.
Determination of the plasmid maintenance rate
At the end of cultivation for L-lysine production, the cells were diluted at appropriate densities in saline and then plated on kanamycin-free BY agar medium, followed by replication of the emerging cells both on the kanamycin-free and on the kanamycin-containing BY plates. The value was calculated as the rate of the number of kanamycin-resistant isolates to the number of isolates on kanamycin-free BY.
Recombinant DNA techniques
Standard protocols (Sambrook and Russell, 2001) were used for the construction, purification, and analysis of plasmid DNA and for the transformation of E. coli. The extraction of C. glutamicum chromosomal DNA and transformation of C.
glutamicum by electroporation were performed as described previously (Takeno et al., 2007) .
Identification of a mutation in strain RE2
A suppressor mutation in strain RE2 was identified via a comparative genome analysis with its parental strain GPN. Whole genome sequencing of strains RE2 and GPN was performed by TaKaRa Bio Inc. (Shiga, Japan) using an Illumina Genome
Analyzer IIx (Illumina, San Diego, CA).
Strain construction
For replacement of the chromosomal iolT1 gene (Cgl0181, NCgl0178) with the homologous gapA gene (Cgl1588, NCgl1526), plasmid pCPiolT1-gapA was constructed as follows. The upstream and downstream region of the iolT1 gene open reading frame (ORF) (for convenience, these regions were referred to as fragments A and B, respectively) were amplified by pairs of primers (the pair comprising Cgl0181delFt and Cgl0181upFusR, and Cgl0181delR and Cgl0181downFusF, respectively), with strain RE2 genomic DNA as a template. The gapA gene was amplified by PCR using two primers, GapAFusForf and GapAFusRorf, with the wild-type ATCC 13032 genomic DNA. Fragment A, the gapA gene, and fragment B were fused stepwise using PCR. The resulting 2.2-kb fragment was digested with BamHI and then ligated to BamHI-digested pESB30 to yield pCPiolT1-gapA. Defined chromosomal replacement of the iolT1 gene was accomplished via two recombination events with the plasmid, as described previously (Ohnishi et al., 2002) . The resulting strain was designated strain RE2A iol .
For the chromosomal deletion of the zwf gene (Cgl1576, NCgl1514), plasmid pCΔzwf, which contains the internally deleted zwf gene, was constructed as follows.
8
The 5' region of the zwf gene was amplified using the primers CGLzwfup200F and zwfFusR, with wild-type ATCC 13032 genomic DNA as the template. Similarly, the 3' region of the gene was amplified using the primers zwfFusF and CGLzwfdown500R.
The 5' and 3' regions were fused by PCR using the primers CGLzwfup200F and CGLzwfdown500R. The resulting 1.6-kb fragment contained the deleted zwf gene, which was shortened by an in-frame deletion from 1,545 to 831 bp, and thus was devoid of the coding region for its active site (PROSITE motif PS00069). The fragment was digested with BglII and then ligated to BamHI-digested pESB30 to yield pCΔzwf.
Defined chromosomal deletion of the zwf gene was accomplished via two recombination events with the plasmid.
RNA extraction, cDNA synthesis, and quantitative PCR
Extraction of total RNAs from C. glutamicum strains and subsequent purification were performed according to the methods described previously . Synthesis of cDNA was performed with 300 ng of RNA by the methods described by Kind et al. (2011) . Quantitative-PCR (qPCR) analysis was performed by the method described by Katayama et al. (2013) . The gene expression levels were standardized to the constitutive level of 16S rRNA expression and calculated by the comparative cycle threshold method (Schmittgen and Livak, 2008) .
Preparation of the soluble fraction and enzyme assays
For GapA and GapN assays, cells at the desired growth phase were collected by centrifugation at 10,000g for 10 min and washed twice with 50 mM triethanolamine hydrochloride (pH 8.0) containing 1 mM EDTA and 1mM dithiothreitol. The cells were suspended in 4 volumes of the same buffer and sonicated on ice for 10 min using a UD-200 ultrasonic disruptor (Tomy Seiko Co., Ltd., Tokyo, Japan). Cell debris was 9 removed by centrifugation at 10,000g for 10 min, and the supernatant was further ultracentrifuged at 100,000g for 90 min using an Optima TL ultracentrifuge (Beckman Coulter, Inc., Fullerton, CA). The resulting supernatant was provided for GapA and GapN assays. Soluble fractions for the G6PDH assay were prepared using the same method as for GapA and GapN assays except for the buffer, which was 100 mM Tris-HCl (pH 7.5) containing 10 mM MgCl 2 and 0.75 mM dithiothreitol. All steps were performed at 4ºC unless otherwise stated. GapA and GapN activities were measured according to the methods described by Omumasaba et al. (2004) and by Crow and Wittenberger (1979) , respectively. G6PDH activity was measured according to the method described by Becker et al. (2007) . All of the enzyme activities were spectrophotometrically measured using an Ultrospec 3000 spectrophotometer (Amersham Pharmacia Biotech, Cambridge, UK). One unit of activity is defined as 1 µmol of NAD(P)H formed per min.
Determination of NADPH/NADP+ ratio
One volume of culture broth was mixed with two volumes of cold 60% methanol plus 70 mM HEPES for quenching the intracellular metabolism, according to the methods described previously (Yamauchi et al., 2014; Faijes et al., 2007) . Cells were then collected by centrifugation and washed twice with saline, followed by removal of suspended CaCO 3 by flash centrifugation. Extraction and determination of intracellular NADPH and NADP + were performed using an EnzyChrom NADP + /NADPH assay kit (BioAssay System, Hayward, CA).
Analysis
Bacterial growth was monitored by measuring the optical density at 660 nm (OD 660 ) of the culture broth with a Miniphoto 518R spectrophotometer (Taitec, Saitama, Japan). Glucose concentration was determined using an F kit D-glucose (Roche Diagnostics, Basel, Switzerland). Myo-inositol concentration was determined using a
Myo-inositol assay kit (Megazyme International Ireland, Wicklow, Ireland). L-Lysine
titer was determined as L-lysine HCl, according to the method described by Ohnishi et al. (2005) . Protein content was determined using a Bio-Rad protein assay kit (Bio-Rad Laboratories).
Results
Identification of the suppressor mutation in strain RE2
Strain RE2 is a spontaneous suppressor mutant isolated from the culture of strain GPN that has the S. mutans gapN gene instead of the native gapA and gapB genes.
While strain GPN showed poor growth on MM medium, strain RE2 exhibited improved growth on the medium (Takeno et al., 2010) , and thus, this suppressor mutant is considered to have a particular mutation that confers increased ability to grow on sugar.
To identify the mutation, we conducted comparative genomic analysis between strain RE2 and its parental strain GPN. The analysis revealed only one specific mutation, a C-to-T exchange at nucleotide position 2086 in the rho gene (Cgl1199, NCgl1152) for the transcription termination factor Rho, which led to the replacement of Arg-696 with Cys (designated mutation rho696). Introduction of mutation rho696 into the strain GPN genome resulted in the same growth profile as strain RE2 in both MM medium and fermentation medium LFG1 containing 5% glucose (data not shown). These results revealed that the suppressor mutation in RE2 is rho696.
Evaluation of strain RE2 as a host for L-lysine production
In our previous report, strain RE2 was found to be a more likely potential host for L-lysine production than the wild-type and ΔgapB strains, based on the final L-lysine titer (Takeno et al., 2010) . However, its performance should be evaluated also in terms of the L-lysine production rate (productivity) because the economy of the L-lysine fermentation process depends mainly on the fermentation yield and the productivity of the overall process. To examine the fermentation profile in detail, strain RE2 and the control ΔgapB strain were engineered to produce L-lysine by introduction of plasmid pCAK311 [lysC(T311I)] (Takeno et al., 2010) . The resulting plasmid carriers were cultivated in BY medium containing 2% glucose as a seed culture, followed by cultivation in 30 mL of LFG1 medium containing 5% glucose in 300-mL baffled Erlenmeyer flask (Fig. 2) . Under these conditions, strain RE2/pCAK311 produced 2.4-fold more L-lysine (64.4 mM, Fig. 2B ) than the control ΔgapB/pCAK311 strain (27.1 mM, Fig. 2A ), reconfirming that strain RE2 is a high-potential host for L-lysine production. However, strain RE2/pCAK311 required almost 40 h to complete fermentation ( Fig. 2G) , while the control ∆gapB/pCAK311 strain took only 24 h (Fig.   2F ). Consequently, the L-lysine production rate in strain RE2/pCAK311 (1.61 mM/h) remains 1.4-fold higher than that of the ΔgapB/pCAK311 strain (1.13 mM/h), even though there was a 2.4-fold increase in the final L-lysine titer.
Further engineering of strain RE2 for more efficient L-lysine production
Although strain RE2 is a high-potential host for L-lysine production, its severely retarded growth despite the suppressor mutation needs to be addressed.
Because strain RE2 originates from strain GPN, which was constructed so that the enzymatic steps to generate NADH and ATP (by GapA and the following 3-phosphoglycerate kinase) were replaced with one to generate NADPH only (by GapN; Figs. 1 and 3), this engineering favors the generation of reducing power but is theoretically disadvantageous regarding ATP generation (Fig. 1) . Our strategy for solving this problem was to use GapA together with GapN in the early growth phase 12 where more ATP is required for growth, and thereafter shift the combination-type glycolytic pathway to one that depends only on GapN for production in the subsequent growth phase. This process requires a system to: (i) control the gapA expression level or GapA activity at the effective level in the early growth phase; and (ii) reduce them to the lowest possible level in the subsequent growth phase. To develop this process, we planned to use the native promoter of the endogenous iolT1 gene encoding a myo-inositol transporter because the promoter is known to be induced by myo-inositol even in the presence of glucose (Krings et al., 2006) . In addition, since the inducer myo-inositol can be co-metabolized with glucose by C. glutamicum (Krings et al., 2006) , it is also expected that the gapA expression level is reduced during fermentation. Thus, a new strain, strain RE2A iol , was constructed by replacing the chromosomal iolT1 gene of strain RE2 with the endogenous gapA gene (Fig. 3) . Although strain RE2A iol lacked the iolT1 gene, the strain could grow on myo-inositol due to the existence of additional transporter encoded by iolT2 (Cgl3058, NCgl2953). We then examined culture conditions to verify the feasibility of the strategy.
After a variety of examinations, we found that the following combination leads to our desired effective L-lysine production: seed culture grown in BY medium added with myo-inositol and then transferred into the main LFG1 medium without myo-inositol (Fig. 2) . When seed culture that was grown on 2% glucose was used as inoculum, strain RE2A iol /pCAK311 produced a comparable level of L-lysine (68.8 mM, Fig. 2C ) for a comparable period (40 h, Fig. 2H ), compared with strain RE2/pCAK311 that was precultured under the same conditions ( Fig. 2B and G) . This suggests that glycolysis is still almost entirely dependent on GapN under these conditions. In contrast, when seed culture that was grown on 2% myo-inositol was used as inoculum, strain RE2A iol /pCAK311 required only a 24-h fermentation period (Fig. 2J ) and still maintained a high level of L-lysine production (57.8 mM, Fig. 2E ), which corresponds to a 2.1-fold higher L-lysine titer than that in the ΔgapB/pCAK311 ( Fig. 2A and F) . On the other hand, when seed culture that was grown on 1.5% glucose plus 0.5% 13 myo-inositol were used as inoculum, strain RE2A iol /pCAK311 required 32 h (Fig. 2I), and produced 2.4-fold more L-lysine (65.3 mM, Fig. 2D ) than the ΔgapB/pCAK311 strain. The final L-lysine titers by strain RE2A iol /pCAK311 decreased in a stepwise manner in order of increasing myo-inositol concentration in the seed medium, whereas its L-lysine production rate increased in the opposite order as follows: 1.72 mM/h for 2% glucose, 2.04 mM/h for 1.5% glucose plus 0.5% myo-inositol, and 2.41 mM/h for 2% myo-inositol. Myo-inositol that was carried over to the main medium at different concentrations slowly decreased from the beginning of the cultivation (Fig. 2I and J) .
Such a decline in myo-inositol starting from the early growth phase was judged to be beneficial to our strategy to reduce the gapA expression level in the rest of the growth phase. The plasmid maintenance rate at the end of cultivation was more than 97.0% in all cultures shown in Fig. 2 . Next, we verified whether these positive results were derived in accordance with our intention.
The gapA and gapN transcript levels during L-lysine production
We conducted a time-course analysis of gapA and gapN transcript levels in strain RE2A iol /pCAK311 during L-lysine production (Fig. 4) . The data for gapA and gapN are presented as relative values to those obtained for the corresponding genes at 8 h in the control strains ΔgapB/pCAK311 (for gapA) and RE2/pCAK311 (for gapN), respectively, both of which were obtained using seed culture on glucose. The gapA transcript levels in the control strain ΔgapB/pCAK311 (Fig. 4A ) and the gapN transcript levels in the other control strain RE2/pCAK311 (Fig. 4B) were generally higher in the early growth phase than in the following growth phase and then decreased gradually as the growth proceeded. A similar pattern was also observed for gapN in the newly engineered strain RE2A iol /pCAK311, regardless of the seed culture conditions ( Fig. 4C-E). These data indicate that our selected conditions do not substantially influence gapN expression in itself. However, the gapA transcript level in strain 14 RE2A iol /pCAK311 differed depending on the seed culture conditions with different composition of glucose and myo-inositol. For glucose only (2%), the gapA transcript level was at the basal level throughout the cultivation (Fig. 4C) . However, for myo-inositol only (2%), the gapA transcript level was maximal in the early exponential phase (at 8 h), which corresponds to approximately 60% of the control value, and thereafter fell to remarkably low levels in the mid-exponential phase (at 16 h; Fig. 4E ).
On the other hand, for glucose (1.5%) plus myo-inositol (0.5%), the gapA transcript level was similarly maximal in the early exponential phase (at 8 h), which is approximately 27% of the control value, and it then fell to the same basal level as observed for glucose in the mid-exponential phase (at 16 h; Fig. 4D ). These data indicate that the gapA expression level in the early exponential phase is controlled by myo-inositol in a dose-dependent manner under the coexistence of glucose, and it is reduced to low levels in the mid-exponential phase as myo-inositol decreases.
The GapA and GapN enzymatic activities during L-lysine production
Besides the transcript levels, GapA and GapN activities during L-lysine production were determined (Table 1) . Whereas NADP-dependent GapN activities in strain RE2A iol /pCAK311 and in strain RE2/pCAK311 were not substantially different in each corresponding growth phase regardless of the seed culture conditions, NAD-dependent GapA activities in strain RE2A iol /pCAK311 were clearly different among the seed culture conditions. For glucose only, GapA activity was not detected in strain RE2A iol /pCAK311. However, for glucose plus myo-inositol, GapA activity was detected at a relatively moderate level in the early exponential phase (181.8 mU/mg at 8 h) but it was absent in the mid-exponential phase (at 16 h). On the other hand, for myo-inositol only, GapA activity was remarkably high in the early exponential phase (571.9 mU/mg at 8 h) and declined to low levels in the mid-exponential phase (58.2 mU/mg at 16 h). These data, together with the gene expression data (Fig. 4) , show that the gapA transcript level was positively correlated with GapA activity and that the elevated growth rate of strain RE2A iol /pCAK311 by myo-inositol supplementation was accompanied by increasing GapA activity, especially in the early exponential phase.
Effect of zwf disruption on L-lysine production
As described in the introduction, contribution of the PPP to L-lysine production was thought to be insignificant in strain RE2, and also presumably in strain RE2A iol .
Even though carbon flux analysis was one of the methods of verifying the hypothesis, we selected a more direct method, by which effect of blocking the oxidative PPP on L-lysine production was investigated. If the hypothesis is true, the PPP blockade has no impact on or hardly affects L-lysine production by strain RE2/pCAK311 and RE2A iol /pCAK311. Thus, PPP mutants, strains RE2Δzwf and RE2A iol Δzwf, together with the ΔgapBΔzwf strain as a control, were constructed by in-frame deletion of the chromosomal zwf gene encoding G6PDH. The soluble fractions from the zwf-disrupted strains ΔgapBΔzwf/pCAK311, RE2Δzwf/pCAK311, and RE2A iol Δzwf/pCAK311 exhibited no G6PDH activity, whereas those from strains ΔgapB/pCAK311, RE2/pCAK311, and RE2A iol /pCAK311 showed G6PDH activities of 94.4 mU/mg, 84.5 mU/mg, and 123.5 mU/mg, respectively.
The resulting strains were examined for their growth properties and L-lysine production (Fig. 2) . Deletion of the zwf gene in the ΔgapB/pCAK311 strain reduced its L-lysine level by approximately 60% (Fig. 2A) , and caused a lower growth level and prolongation of the cultivation period to 32 h (Fig. 2F) . However, the gene deletion in strain RE2 hardly affected both L-lysine production and growth ( Fig. 2B and G) . The same results were obtained in strain RE2A iol /pCAK311 for the seed culture conditions with glucose only (Fig. 2C and H) and with glucose plus myo-inositol ( Fig. 2D and I ).
These data demonstrate that the oxidative PPP is, as expected, unnecessary for L-lysine production by these strains. Meanwhile, somewhat obvious decrease in the final 16 L-lysine titer by deletion of the zwf gene was observed for the seed culture conditions with myo-inositol only (Fig. 2E) . Considering the slower production rate of L-lysine in the early exponential phase compared with that in the subsequent growth phase, it is likely that the induced GapA activity in the early exponential phase raised the need for NADPH through the PPP, especially in the early exponential phase.
Intracellular NADPH/NADP + ratio during L-lysine production
Although L-lysine production by strains RE2/pCAK311 and RE2A iol /pCAK311
were well over 2.0-fold higher than that by the control ∆gapB/pCAK311 strain, avoidance of carbon loss resulting from bypassing the PPP alone never explains the marked increase beyond 1.2-fold as a theoretical maximum. Thus, we hypothesized that the NADPH-generating glycolytic pathway using GapN would give rise to elevated NADPH levels, which resulted in acceleration of L-lysine biosynthesis. To verify this hypothesis, the intracellular NADPH/NADP + ratio was determined using cells grown to the mid-exponential phase. Culture conditions for each strain were identical to those performed in Fig. 2 . The ratio was 0.329±0.01 for the ∆gapB/pCAK311 strain (at 16 h).
On the other hand, the ratio in either strain RE2/pCAK311 or strain RE2A iol /pCAK311 irrespective of seed culture conditions was significantly higher than that obtained by the ∆gapB/pCAK311 strain. It was 0.533±0.08 in strain RE2/pCAK311 (at 24 h), 0.570±0.03 in strain RE2A iol /pCAK311 for glucose (at 32 h), 0.526±0.08 in strain RE2A iol /pCAK311 for glucose plus myo-inositol (at 16 h), and 0.445±0.01 in strain RE2A iol /pCAK311 for myo-inositol only (at 16 h). These values are correlated with L-lysine production shown in Fig. 2 , which almost has a quantitative relationship.
Deletion of zwf has little to no influence on L-lysine production by strains RE2/pCAK311 and RE2A iol /pCAK311 (Fig. 2) 
Discussion
We showed that the suppressor mutant RE2, which mainly generates NADPH through the glycolytic pathway, is a high-potential host for L-lysine production. The suppressor mutation was elucidated to be a point mutation in the rho gene (rho696).
However, despite the presence of the mutation, strain RE2 still showed a lower growth rate on glucose than the wild-type and ΔgapB strains. This drawback was overcome by taking advantage of GapA using the myo-inositol-inducible expression system in combination with simple seed culture conditions. This engineering led to improved growth while maintaining higher L-lysine productivity: strain RE2A iol /pCAK311
showed an approximately 1.3-to 1.5-fold higher production rate than did strain RE2/pCAK311 (Fig. 2B , D and E), which was approximately 1.8-to 2.1-fold higher than the ΔgapB/pCAK311 strain ( Fig. 2A, D and E) . The elevated growth rate was shown to be accompanied by increasing GapA activity, especially in the early exponential phase (Table 1) . The most noteworthy achievement in the present study was that, unlike in the control ∆gapB/pCAK311 strain, the oxidative PPP blockade by the zwf gene deletion had little to no effect on both L-lysine production and the fermentation period in strains RE2/pCAK311 and RE2A iol /pCAK311 (Fig. 2) , demonstrating that the oxidative PPP is not significant in these strains. Therefore, we conclude that the NADPH-generating glycolytic pathway using GapN eliminates the need for the oxidative PPP in the efficient production of L-lysine by C. glutamicum. Considering that 4 mol of NADPH is required for 1 mol of L-lysine production, and also that 2 mol of NADPH is inevitably generated from 1 mol of glucose at the GapN step, the engineered GapN strains can theoretically supply the NADPH required for L-lysine biosynthesis up to a yield of 0.5 mol L-lysine/mol of sugar, regardless of the flux distribution between glycolysis and the PPP. Because the L-lysine yields by the GapN strains are still below the theoretical upper limit, the GapN strains are thought to supply a sufficient amount of NADPH to its L-lysine biosynthesis through the reconstructed glycolytic pathway without depending on the PPP. This study is the first to demonstrate efficient L-lysine production independent of the oxidative PPP. The results of the present study are summarized in Fig. 5 .
The suppressor mutation rho696, which led to the replacement of Arg-696 with Cys in the transcription termination factor Rho protein, improved the growth of strain GPN on glucose. This was confirmed not only by the whole genomic analysis of the suppressor mutant RE2 but also introduction of the mutation into the parental strain GPN. However, causal effects of rho696 on the growth improvement remain to be elucidated. Homology analysis provided the following information: i) Arg-696 is located in the C-terminal region of C. glutamicum Rho where there is a highly conserved region among a wide variety of bacterial Rho proteins, including those of E.
coli and Bacillus subtilis; and ii) the Arg-696 residue is strictly conserved among bacterial Rho and also corresponds to an Arg residue at amino acid position 366 in E.
coli Rho. It has been reported in E. coli Rho that replacement of the Arg-366 with His causes a complete defect in transcription termination in vivo because of a severe decrease in its RNA-dependent ATPase activity (Miwa et al., 1995) . Therefore, the rho696 mutation is likely to damage Rho transcription termination activity. Moreover, it has been reported in E. coli Rho that defects in termination cause a 10-to 20-fold increase in read-through efficiency (Chalissery et al., 2007) . Therefore, increased expression of a certain gene(s) is possibly caused by read-through transcription over the Rho-dependent transcription termination site because of rho696, and among such gene(s), there seems to be a candidate(s) to make the GapN-dependent glycolytic pathway work more efficiently. Recently, it has been reported that the severe growth defect of the high NADPH-generating C. glutamicum strain, where the pgi gene encoding the phosphoglucose isomerase was deleted, is not caused by increased intracellular NADPH concentrations, as previously predicted, but by the negative effect on glucose uptake, which is caused by a strongly reduced level of PtsG component in phosphotransferase system (PTS) by a still-unknown mechanism (Lindner et al., 2013) .
It is not unreasonable for these findings to be applied to our high NADPH-generating strain. Thus, rho696 might cause increased levels of PtsG and/or balance the intracellular amount of phosphoenolpyruvate and pyruvate, which are the substrate and product for PTS, respectively, to support the PTS-dependent glucose uptake.
Very recently, it was reported that Clostridium acetobutylicum gapN expression does not allow the C. glutamicum ATCC 13032 ΔgapAB strain to grow in glucose minimal medium (Komati Reddy et al., 2015) . All four suppressor mutants obtained by these researchers shared only one specific mutation: a single point mutation in the ndh gene encoding non-proton-pumping NADH:ubiquinone oxidoreductase (NDH-II), which leads to the amino acid change D213G. The mutated NDH-II was shown in vitro to oxidize NADH and also NADPH. They reasonably concluded that the growth inhibition in their gapN-expressing strain was a result of excess NADPH and that the mutation is responsible for oxidation of NADPH to NADP + coupled with electron transport phosphorylation, resulting in ATP generation. Taking their results into consideration, mutation rho696 should likely be dealt with from NADPH reoxidation and/or ATP generation. However, in our case, it is difficult to suppose that mutation rho696 causes NADPH reoxidation to NADP + , because no growth improvement in strain GPN was observed by engineering for L-lysine overproduction, i.e., by 20 construction of the pathway that consumes a large amount of NADPH (Takeno et al., 2010) . Thus, we suggest that mutation rho696 leads to improved ATP generation rather than to NADPH reoxidation. It should be noted that, besides bypassing ATP generation in the glycolysis, metabolic engineering using GapN is likely to reduce carbon flux through the TCA cycle and thereby to decrease NADH supply for ATP generation by oxidative phosphorylation. This point is discussed later, again.
The growth of strain RE2A iol /pCAK311 was gradually improved as GapA activity was increased, especially in the early exponential phase (Fig. 2H-J and Table 1 ).
Although improved growth still maintains the high L-lysine productivity, the GapA activity was somewhat negatively correlated with final L-lysine production ( Fig. 2C-E) ,
suggesting that use of GapA causes the decrease in NADPH supply. Actually, the NADPH/NADP + ratio in strain RE2A iol /pCAK311 was relatively lower under conditions where the GapA activity was present (the ratio of 0.445±0.01) compared with when no GapA activity was observed (the ratio of 0.526±0.08 to 0.570±0.03). The reasonable explanation is that the increased involvement of GapA in glycolysis leads to growth improvement, presumably because of ATP generation, but concomitantly reduces GAP availability for GapN, resulting in a decrease in the NADPH supply.
Considering that excessive dependency on GapA negatively affects L-lysine production in the engineered GapN strains, the advantage of the system developed in the present study is to allow cells to reconcile growth with lysine production in a well-balanced state.
It is also worth noting that the glycolytic pathway using GapN leads to efficient L-lysine production independent of the oxidative PPP, which was verified by confirming that blocking the oxidative PPP by deleting the zwf gene has little effect both on L-lysine production and on the high NADPH/NADP + ratio in either strains RE2/pCAK311 or RE2A iol /pCAK311 ( Fig. 2B-E) . Recently, it has been reported that the engineering of the C. glutamicum glycolytic pathway using a modified GapA variant that showed a preference toward both NAD + and NADP + resulted in increased L-lysine 21 production (1.25-to 1.65-fold higher production). However, this barely changed carbon fluxes through the PPP (Bommareddy et al., 2014) , suggesting that remnant of NAD-reactive properties of GapA inevitably draws the necessity of the PPP. Similar results might be seen for strain RE2A iol /pCAK311 in the early exponential phase where considerable GapA activity coexisted with GapN (Fig. 2E ). Under these conditions, the PPP blockade has a somewhat distinguishable impact on L-lysine production. Besides engineering for redirection of carbon toward the PPP, the heterologous expression of pntAB genes, which encode a membrane-bound transhydrogenase catalyzing the interconversion of NADH and NADPH, increases L-lysine production on glucose;
however, the PPP has been suggested to still contribute to the sufficient NADPH supply (Kabus et al., 2007) .
In this study, construction of S. mutans-type glycolytic pathway in C.
glutamicum has led to an impressive result in L-lysine production. The better-than-expected result seems to be partly due to the avoidance of carbon loss through the oxidative PPP, but rather due to the increased intracellular NADPH/NADP + ratio. It has been reported that, on fructose compared with on glucose, carbon flux through the PPP is significantly decreased (62.0% to 14.4%), and that through the TCA cycle is increased (52.9% to 83.3%) for a partial compensation of the anabolic NADPH requirement (Kiefer et al., 2004) . Considering conversely, carbon flux through the TCA cycle is likely reduced in our high NADPH-generating strain. In fact, deletion of phosphoglucose isomerase, which is the radical strategy for NADPH supply by which almost all glucose fluxes through the PPP, decreased the flux through the TCA cycle during L-lysine production (Marx et al., 2003) . Therefore, it seems reasonable to consider that the high NADPH/NADP + ratio obtained in the present study not only allows cells to bypass the PPP but also causes a decreased flux through the TCA cycle.
This would cause increased availability of oxaloacetate supplied through anaplerotic pathways and result in augmented L-lysine biosynthesis.
As shown here for L-lysine, the strain engineered to generate NADPH through 22 glycolysis is likely to be an effective host for other NADPH-requiring compounds, such as other amino acids , commodity chemicals (Kind et al., 2011; Song et al., 2013) , vitamins (Hüser et al., 2005; , fatty acids , and carotenoids (Heider et al., 2012) . The results of the present study will pave the way for efficient production of these compounds. (A) and strain RE2/pCAK311 (for gapN) (B), respectively. The data for the ΔgapB/pCAK311 strain that was precultured on 2% glucose is presented in (A), for strain RE2/pCAK311 that was precultured on 2% glucose is presented in (B), for strain RE2A iol /pCAK311 that was precultured on 2% glucose is presented in (C), for strain RE2A iol /pCAK311 that was precultured on 1.5% glucose plus 0.5% myo-inositol is presented in (D), and for strain RE2A iol /pCAK311 that was precultured on 2%
Figure Legends
myo-inositol is presented in (E). Data represent mean value from three independent cultures, and the standard deviation from the mean is indicated as error bars. maintaining its high ability to produce L-lysine using GapA at an effective level in the early exponential phase. Decline in GapA activity from the early to mid-exponential phase is represented with a gradational arrow in strain RE2A iol (rightmost). The best result of strain RE2A iol in terms of production rate was obtained using seed culture on 2% myo-inositol. In this condition, the newly engineered strain gave 2.1-fold higher L-lysine titer than the control ΔgapB/pCAK311 strain for a comparable period, and yielded a production rate of 2.41 mM/h. In conclusion, well-balanced use of GapA and GapN in strain RE2A iol led to both improved growth and high-level L-lysine production that is independent of the PPP. Abbreviations are as described in the legend to Fig. S1 . 
